Autoimmune Dementia clinical trials

Explore recruiting autoimmune dementia clinical trials.

Recruiting autoimmune dementia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Autoimmune Dementia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A double-blinded, randomized, placebo-controlled, multi-center trial of Efgartigimod in autoimmune dementia (EfgaDem)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Autoimmune Dementia trials by city

Autoimmune Dementia in Toronto Autoimmune Dementia in Vancouver Autoimmune Dementia in Montreal Autoimmune Dementia in Calgary Autoimmune Dementia in Edmonton Autoimmune Dementia in Ottawa Autoimmune Dementia in Winnipeg Autoimmune Dementia in Quebec City Autoimmune Dementia in Hamilton Autoimmune Dementia in Kitchener Autoimmune Dementia in London Autoimmune Dementia in Halifax Autoimmune Dementia in New York Autoimmune Dementia in Los Angeles Autoimmune Dementia in Chicago Autoimmune Dementia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease